Compare PRAN to:
After Hours: 0.00 N/A (N/A) 7:00pm ET
| Last Trade: | 1.632 |
|---|---|
| Trade Time: | Nov 25 |
| Change: | |
| Prev Close: | 1.637 |
| Open: | 1.64 |
| Bid: | 1.50 x 2000 |
| Ask: | N/A |
| 1y Target Est: | 8.00 |
| Day's Range: | 1.54 - 1.64 |
|---|---|
| 52wk Range: | 1.00 - 3.11 |
| Volume: | 3,786 |
| Avg Vol (3m): | 20,500 |
| Market Cap: | N/A |
| P/E (ttm): | N/A |
| EPS (ttm): | N/A |
| Div & Yield: | N/A (N/A) |
| Wed, Nov 11 | Prana Selected to Present at Windhover's Therapeutic Area Partnerships Conference by Independent ExpertGlobeNewswire |
| Tue, Sep 29 | PRANA BIOTECHNOLOGY LTD FinancialsEDGAR Online Financials |
| Wed, Sep 9 | Prana Secures $6 Million Additional FinancingGlobeNewswire |
| Wed, Sep 2 | Prana Biotechnology to Present At the Rodman and Renshaw Annual Global Investment ConferenceGlobeNewswire |
| Wed, Aug 12 | Prana Allowed Key Patent for PBT2 in the United StatesGlobeNewswire |
| Wed, Aug 5 | Prana is Granted Key Patent by European Patent OfficeGlobeNewswire |
| Wed, Jul 15 | Prana's Head of Research Presents New Efficacy Data in Hot Topics Session At ICADGlobeNewswire |
| Fri, Jul 10 | Prana to Provide Update on PBT2 Efficacy dataMarketwire |
| Wed, Mar 11 | Prana's PBT2 Prevents Synaptic Loss in Alzheimer's DiseaseMarketwire |
| Mon, Jan 5 | Prana Co-Founding Scientist Dr. Rudolph Tanzi to Present at the 2009 Goldman Sachs Healthcare CEOs Unscripted: A View From the Top ConferenceMarketwire |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.